Abstract
1. The potency of hellebrin, hellebrigenin, hellebrigenin monoacetate and hellebrigenol monoacetate has been compared with desgluco-hellebrin in etherized cats. Hellebrin is less active than desgiuco-hellebrin. Unexpectedly the aglycone hellebrigenin is more potent than either hellebrin or desgluco-hellebrin. Hellebrigenin monoacetate is more active than hellebrigenol monoacetate, and it is the most potent cardiac product so far studied.
2. Hellebrin, hellebrigenin and its monoacetate, and hellebrigenol monoacetate, all produce vomiting in pigeons and cats, and cause contractions in smoothmuscle organs.
Footnotes
- Received March 29, 1950.
- 1950 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.